ICTAMMOLO ALMUS

PACKAGE LEAFLET

Ictammolo Almus 10% ointment

PHARMACOTHERAPEUTIC CATEGORY
Preparations containing sulfur
THERAPEUTIC INDICATIONS
Inflammations and minor skin infections.
Furunculosis (boils), abscesses, and superficial skin ulcers.
Inflammation of the sweat glands (hidradenitis).
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
PRECAUTIONS FOR USE
Do not apply near the eyes or on mucous membranes.
Avoid exposure to sunlight and UVA rays after application.
The use, especially if prolonged, of topical medicines may lead to irritation or sensitization.
If this occurs, discontinue treatment and contact your doctor, who may prescribe appropriate therapy.
INTERACTIONS
Inform your doctor or pharmacist if you have recently taken any other
medicine, including those without a prescription.
No specific interaction studies have been performed.
SPECIAL WARNINGS
Pregnancy and breastfeeding
Consult your doctor or pharmacist before taking any medicine.
In the absence of specific studies, the medicine should be used during pregnancy and breastfeeding only if necessary and under direct medical supervision.
Effects on ability to drive vehicles and use machinery
The medicine does not affect the ability to drive vehicles or operate machinery.
DOSAGE, METHOD AND DURATION OF ADMINISTRATION
Apply the ointment, in the amount necessary according to the area to be treated, 2–3 times daily, covering the area with gauze.
Ictammolo is incompatible with acids, alkalis, alkaloids, and iron salts.
OVERDOSE
If used in excessive amounts, it may be irritating to the skin and mucous membranes.
In case of accidental ingestion/overdose of Ictammolo Almus, contact your doctor immediately or go to the nearest hospital.
IF YOU HAVE ANY DOUBTS ABOUT THE USE OF ICTAMMOLO ALMUS, CONSULT YOUR
DOCTOR OR PHARMACIST.
UNDESIRABLE EFFECTS
Like all medicines, Ictammolo can cause side effects, although not everybody gets them.
The following undesirable effects of Ictammolo are reported. There are insufficient data to determine the frequency of the individual listed effects.
Skin and subcutaneous tissue disorders
Dermatitis, Burning sensations, Skin irritations, Hypersensitivity reactions
Following the instructions in this leaflet reduces the risk of undesirable effects.
If any of the undesirable effects worsen, or if you notice any undesirable effect not listed in this leaflet, inform your doctor or pharmacist.
EXPIRY DATE AND STORAGE
Expiry date: see the date printed on the packaging
The expiry date refers to the product in unopened packaging, correctly stored.
WARNING: do not use the medicine after the expiry date stated on the packaging.
Storage conditions
Keep the tube tightly closed in the original packaging.
Medicines must not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Keep the medicine out of the reach and sight of children.
COMPOSITION
100 g of ointment contain
Active substance: ammonium sulfosuccinate 10 g
Excipients: white vaseline
PHARMACEUTICAL FORM AND CONTENT
Ointment.
MARKETING AUTHORISATION HOLDER
Almus S.r.l. - Via Cesarea, 11/10 – 16121 Genoa
MANUFACTURER
Zeta Farmaceutici S.p.A. - Via Galvani, 10 - 36066 Sandrigo (VI)